Organon
Commercializes women's health medicines, biosimilars, and established brands.
$13.76
After-hours close0.00 (0.00%)
At close$13.76(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 86.01%225.86M sharesInsiders 0.47%1.24M sharesOther 13.52%35.51M shares
Shares outstanding 262.61M · Float 261.09M · 99.4% free float
Institutions13F, as of Jun 30, 2026
657 holders · 225.86M shares · 130 new positions · 253 increased · 189 reduced · 100 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 32.06M | 12.21% | +339.8K | Aug 7, 2026 |
| Pentwater Capital Management LP | 18.10M | 6.89% | +18.10Mnew | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 15.13M | 5.76% | −6.71M | Aug 13, 2026 |
| Vanguard Capital Management LLC | 11.91M | 4.54% | +172.8K | Aug 13, 2026 |
| State Street Corp | 9.66M | 3.68% | −297.4K | Aug 7, 2026 |
| Goldman Sachs Group Inc | 5.20M | 1.98% | +3.59M | Aug 14, 2026 |
| UBS Group AG | 4.86M | 1.85% | +1.38M | Aug 13, 2026 |
| Geode Capital Management, LLC | 4.82M | 1.83% | +56.3K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 11.90% | 30.66M | 13G | Apr 30, 2025 ↗ |
| Vanguard Portfolio Management | 8.47% | 22.05M | 13G | Apr 29, 2026 ↗ |
| Pentwater Capital Management LP | 6.90% | 18.10M | 13G | Aug 14, 2026 ↗ |
| Vanguard Capital Management | 5.26% | 13.72M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Kevin Ali | director, officer: Chief Executive Officer | 282.7K | 0.11% | May 6, 2025 |
| Matthew M. Walsh | officer: Chief Financial Officer | 198.6K | 0.08% | Apr 2, 2026 |
| Joseph T. Jr. Morrissey | officer: Interim CEO | 111.1K | 0.04% | Apr 2, 2026 |
| Rachel A. Stahler | officer: Chief Information Officer | 108.0K | 0.04% | Apr 2, 2026 |
| Aaron Falcione | officer: Chief Human Resources Officer | 94.1K | 0.04% | Apr 2, 2026 |
| Carrie Smith Cox | director, officer: Executive Chair | 90.3K | 0.03% | Nov 13, 2025 |
| Kirke Weaver | officer: Gen. Counsel & Corp. Secy. | 83.8K | 0.03% | Apr 2, 2026 |
| Vittorio Nisita | officer: Head of Global Business Svcs | 65.1K | 0.02% | Apr 2, 2026 |
| Daniel Karp | officer: Executive VP, Corp. Dev. | 64.9K | 0.02% | Apr 2, 2026 |
| Lynette Holzbaur | officer: SVP and Corporate Controller | 52.9K | 0.02% | May 7, 2026 |
5 people have not refiled in the last 18 months (103.2K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 5, 2026 | Juliana Papa Drinaneofficer: Head of Mfg & Supply | Sale | 14,761 | $13.57 | 18,475 |
| May 6, 2026 | Lynette Holzbaurofficer: SVP and Corporate Controller | Purchase | 26,448 | $13.35 | 52,851 |
| May 6, 2026 | Lynette Holzbaurofficer: SVP and Corporate Controller | Sale | 26,448 | $13.35 | 0 |
| Nov 12, 2025 | Carrie Smith Coxdirector, officer: Executive Chair | Purchase | 65,400 | $7.67 | 77,869 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Kevin Hern · OK01 | Sale | $1,001 – $15,000 | Joint | Aug 5, 2026 | Aug 11, 2026 ↗ |